HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1201	6611 Duyckaerts C, Colle MA, Hauw JJ A sketch of Alzheimer's disease histopathology ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 137-151	1	2	25	113
1202	6612 Tapiola T, Lehtovirta M, Pirttila T, Alafuzoff I, Riekkinen P, et al. Cerebrospinal fluid aspartate aminotransferase activity is increased in Alzheimer's disease ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 193-197	0	0	3	15
1203	6613 Grunberg J, Walter J, Haass C The 18-20 kDa C-terminal fragment of presenilin-1 is the major in vivo substrate for proteases of the caspase family ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 213-220	0	0	6	23
1204	6614 Goedert M, Crowther RA, Jakes R, Hasegawa M, Smith MJ, et al. Filamentous tau protein and alpha-synuclein deposits in neurodegenerative diseases ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 245-258	1	2	32	42
1205	6615 Arawaka S, Sahara N, Lee G, Mori H Molecular anatomy of tau inclusions with antibodies to specifically recognize tau isoforms ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 259-265	0	0	20	36
1206	6616 Iqbal K, Alonso AD, Gondal JA, Gong CX, Haque N, et al. Inhibition of neurofibrillary degeneration: A rational and promising therapeutic target ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 269-280	0	0	35	68
1207	6617 Novak M, Ugolini G, Fasulo L, Visintin M, Ovecka M, et al. Truncation of tau and neurodegeneration ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 281-291	3	8	10	37
1208	6618 Illenberger S, Zheng-Fischhofer Q, Preuss U, Stamer K, Godemann R, et al. Phosphorylation of tau protein in interphase and mitosis: Influence on microtubules and relationship with PHF-tau in Alzheimer's disease ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 301-310	0	0	10	22
1209	6619 Wang JZ, Grundke-Iqbal I, Iqbal K Protein kinase-A and glycogen synthase kinase-3 in combination hyperphosphorylate tau to an Alzheimer's disease-like state ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 311-321	1	3	29	45
1210	6620 Sisodia SS, Thinakaran G, Borchelt DR, Wong PC, Lee MK, et al. Function and dysfunction of presenilins in Alzheimer's disease ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 333-346	0	0	13	59
#	Date / Author / Journal	LCS	GCS	LCR	CR
1211	6621 Salehi A, Dubelaar EJG, Ishunina TA, Swaab DF Neuronal activity and genetic background in Alzheimer's disease ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 487-492	0	0	7	32
1212	6622 Lantos PL Cracking an enigma: The puzzle of unusual dementias ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 509-522	0	2	14	52
1213	6623 Schwab C, Steele JC, Schulzer M, McGeer PL On the possible lifetime of a tangled neuron in the parkinsonism- dementia complex of Guam ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 545-552	0	0	7	15
1214	6624 Parchi P, Brown P, Capellari S, Gibbs CJ, Gambetti P Agent strain variation in human prion diseases: Insight from transmission to primates ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 561-567	4	4	4	17
1215	6625 Genis I, Fisher A, Shohami E, Michaelson DM Modulation of tau hyperphosphorylation in apoE-deficient mice by muscarinic activation and closed head injury ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 733-740	0	2	7	17
1216	6626 Tsolaki M, Sakka P, Chatzizisi O, Kyriazis G, Papanastasiou J, et al. CSF tau protein levels before and after tacrine therapy in patients with dementia of Alzheimer's type ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 741-745	0	0	4	14
1217	10206 Kakimura J, Kitamura Y, Takata K, Tsuchiya D, Taniguchi T, et al. Possible involvement of ER chaperone Grp78 on reduced formation of amyloid-beta deposits ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY. 2002; 977: 327-332	0	3	6	19
1218	16390 Lee VMY, Trojanowski JQ Tau focused drug discovery for Alzheimer's disease and related Neuroclegenerative Tauopathies ALZHEIMER: 100 YEARS AND BEYOND. 2006; : 333-336	0	0	0	0
1219	18345 Dickey CA, Petrucelli L Commentary on "Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery." The last stand: The dichotomy of chaperone function in Alzheimer's disease ALZHEIMERS & DEMENTIA. 2007 JAN; 3 (1): 3-6	0	1	14	38
1220	18346 Jellinger KA The enigma of mixed dementia ALZHEIMERS & DEMENTIA. 2007 JAN; 3 (1): 40-53	5	11	23	162
#	Date / Author / Journal	LCS	GCS	LCR	CR
1221	18784 Jedrziewski AK, Lee VMY, Trojanowski JQ Physical activity and cognitive health ALZHEIMERS & DEMENTIA. 2007 APR; 3 (2): 98-108	0	0	1	42
1222	19216 Khachaturian ZS A chapter in the development of Alzheimer's disease research: A case study of public policies on the development and funding of research programs ALZHEIMERS & DEMENTIA. 2007 JUL; 3 (3): 243-258	1	5	7	57
1223	19617 Robillard A Clinical diagnosis of dementia ALZHEIMERS & DEMENTIA. 2007 OCT; 3 (4): 292-298	0	5	13	77
1224	19618 Schipper HM The role of biologic markers in the diagnosis of Alzheimer's disease ALZHEIMERS & DEMENTIA. 2007 OCT; 3 (4): 325-332	0	6	37	90
1225	19619 Hogan DB, Bailey P, Carswell A, Clarke B, Cohen C, et al. Management of mild to moderate Alzheimer's disease and dementia ALZHEIMERS & DEMENTIA. 2007 OCT; 3 (4): 355-384	1	17	3	298
1226	19620 Hsiung GYR, Sadovnick AD Genetics and dementia: Risk factors, diagnosis, and management ALZHEIMERS & DEMENTIA. 2007 OCT; 3 (4): 418-427	0	6	22	79
1227	19621 Rockwood K, Bouchard RW, Camicioli R, Leger G Toward a revision of criteria for the dementias ALZHEIMERS & DEMENTIA. 2007 OCT; 3 (4): 428-440	2	4	18	133
1228	20279 Trojanowski JQ, Hendricks JC, Jedrziewski K, Johnson FB, Michel KE, et al. Exploring human/animal intersections: Converging lines of evidence in comparative models of aging ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): 1-5	1	1	1	4
1229	20280 Foster NL, Wanga AY, Tasdizen T, Fletcher PT, Hoffman JM, et al. Realizing the potential of positron emission tomography with F-18- fluorodeoxyglucose to improve the treatment of Alzheimer's disease ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S29-S36	2	7	9	46
1230	20281 Hodes RJ, Buckholtz N, Cahan V, Morrison-Bogorad M Eyes on the prize: Federal Alzheimer's research effort aims to facilitate interventions ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S37-S47	1	3	12	46
#	Date / Author / Journal	LCS	GCS	LCR	CR
1231	20282 Hampel H, Buerger K, Teipel SJ, Bokde ALW, Zetterberg H, et al. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): 38-48	35	69	23	96
1232	20283 Koeppe RA, Gilman S, Junck L, Wernette K, Frey KA Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[C-11]dihydrotetrabenazine positron emission tomography ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S67-S76	3	9	7	33
1233	20284 Kuller LH, Lopez OL Dementia: Is it time for a change in focus? ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S77-S84	0	0	2	50
1234	20285 Sabbagh MN, Richardson S, Relkinc N Disease-modifying approaches to Alzheimer's disease: Challenges and opportunities - Lessons from donepezil therapy ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S109-S118	1	1	5	54
1235	20286 Jackson CE, Snyder PJ Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer's disease ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S137-S143	2	10	6	67
1236	20590 Salloway S, Mintzer J, Weiner MF, Cummings JL Disease-modifying therapies in Alzheimer's disease ALZHEIMERS & DEMENTIA. 2008 MAR; 4 (2): 65-79	9	44	23	172
1237	20591 Ivinson AJ, Lane R, May PC, Hosford DA, Carrillo MC, et al. Partnership between academia and industry for drug discovery in Alzheimer's disease ALZHEIMERS & DEMENTIA. 2008 MAR; 4 (2): 80-88	1	4	3	27
1238	20592 Trojanowski JQ, Duff K, Fillit H, Koroshetz W, Kuret J, et al. New directions for frontotemporal dementia drug discovery ALZHEIMERS & DEMENTIA. 2008 MAR; 4 (2): 89-93	8	8	12	19
1239	20593 Schenk D Commentary on "New directions for frontotemporal dementia drug discovery." Do we know enough to develop meaningful treatments for frontotemporal dementia? ALZHEIMERS & DEMENTIA. 2008 MAR; 4 (2): 94-95	0	0	4	8
1240	20911 Siemers ER, Paul SM Commentary on "A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium" ALZHEIMERS & DEMENTIA. 2008 MAY; 4 (3): 171-173	1	2	2	11
#	Date / Author / Journal	LCS	GCS	LCR	CR
1241	21814 Chiang HH, Rosvall L, Brohede J, Axelman K, Bjork BF, et al. Progranulin mutation causes frontotemporal dementia in the Swedish Karolinska family ALZHEIMERS & DEMENTIA. 2008 NOV; 4 (6): 414-420	0	0	18	23
1242	21815 Griffith HR, den Hollander JA, Okonkwo OC, O'Brien T, Watts RL, et al. Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia ALZHEIMERS & DEMENTIA. 2008 NOV; 4 (6): 421-427	3	5	13	47
1243	21816 Bain LJ, Jedrziewski K, Morrison-Bogorad M, Albert M, Cotman C, et al. Healthy brain aging: A meeting report from the Sylvan M. Cohen Annual Retreat of the University of Pennsylvania Institute on Aging ALZHEIMERS & DEMENTIA. 2008 NOV; 4 (6): 443-446	1	1	2	20
1244	22630 Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, et al. A roadmap for the prevention of dementia II: Leon Thal Symposium 2008 ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 85-92	6	6	0	4
1245	22631 Petersen RC Commentary on "A roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A national registry on aging ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 105-107	0	0	4	12
1246	22632 Simpkins JW, Gatson JW, Wigginton JG Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 143-146	0	0	20	46
1247	22633 Carrillo MC, Blackwell A, Hampel H, Lindborg J, Sperling R, et al. Early risk assessment for Alzheimer's disease ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 182-196	3	5	23	124
1248	22958 Mebane-Sims I, Alzheimer's Association 2009 Alzheimer's disease facts and figures ALZHEIMERS & DEMENTIA. 2009 MAY; 5 (3): 234-270	15	76	3	126
1249	23258 Frisoni GB, Prestia A, Zanetti O, Galluzzi S, Romano M, et al. Markers of Alzheimer's disease in a population attending a memory clinic ALZHEIMERS & DEMENTIA. 2009 JUL; 5 (4): 307-317	7	11	15	48
1250	23259 Black R, Greenberg B, Ryan JM, Posner H, Seeburger J, et al. Scales as outcome measures for Alzheimer's disease ALZHEIMERS & DEMENTIA. 2009 JUL; 5 (4): 324-339	2	4	3	115
#	Date / Author / Journal	LCS	GCS	LCR	CR
1251	23602 Simpkins JW Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier" ALZHEIMERS & DEMENTIA. 2009 SEP; 5 (5): 433-434	0	0	1	1
1252	23945 Lukens JN, Van Deerlin V, Clark CM, Xie SX, Johnson FB Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease ALZHEIMERS & DEMENTIA. 2009 NOV; 5 (6): 463-469	1	4	5	49
1253	24542 Itzhaki RF, Wozniak MA Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? ALZHEIMERS & DEMENTIA. 2010 JAN; 6 (1): 83-84	0	1	2	10
1254	24889 Khachaturian ZS, Barnes D, Einstein R, Johnson S, Lee VMY, et al. Developing a national strategy to prevent dementia: Leon Thal Symposium 2009 ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 89-97	0	0	2	19
1255	24890 Brunnstrom H, Rawshani N, Zetterberg H, Blennow K, Minthon L, et al. Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 104-109	2	3	14	31
1256	24891 Xu SH, Brunden KR, Trojanowski JQ, Lee VMY Characterization of tau fibrillization in vitro ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 110-117	2	2	25	41
1257	24892 Snyder PJ Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." The rationale for a National Institutional Review Board for neurodegenerative diseases ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 135-137	0	0	1	3
1258	24893 Einstein R Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Developing a blood test for Alzheimer's disease using advanced genomic expression technology ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 147-149	0	0	6	20
1259	24894 Trojanowski JQ, Arnold SE, Karlawish JH, Brunden K, Cary M, et al. Design of comprehensive Alzheimer's disease centers to address unmet national needs ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 150-155	0	0	6	18
1260	24895 Sabbagh MN Commentary on "Design of comprehensive Alzheimer's disease centers to address unmet national needs" ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 156-157	0	0	1	11
#	Date / Author / Journal	LCS	GCS	LCR	CR
1261	25250 Weiner MW, Aisen PS, Jack CR, Jagust WJ, Trojanowski JQ, et al. The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 202-211	7	7	3	16
1262	25251 Jack CR, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, et al. Update on the Magnetic Resonance Imaging core of the Alzheimer's Disease Neuroimaging Initiative ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 212-220	5	5	11	39
1263	25252 Jagust WJ, Bandy D, Chen KW, Foster NL, Landau SM, et al. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 221-229	3	4	5	18
1264	25253 Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, et al. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 230-238	6	6	17	37
1265	25254 Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, et al. Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 239-246	4	4	4	10
1266	25255 Beckett LA, Harvey DJ, Gamst A, Donohue M, Kornak J, et al. The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 257-264	0	1	10	28
1267	25256 Saykin AJ, Shen L, Foroud TM, Potkin SG, Swaminathan S, et al. Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 265-273	3	4	5	50
1268	25257 Cairns NJ, Taylor-Reinwald L, Morris JC, Alzheimer's Dis Neuroimaging Initi Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: The essential role of the Neuropathology Core ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 274-279	2	2	11	23
1269	25258 Frisoni GB Alzheimer's Disease Neuroimaging Initiative in Europe ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 280-285	2	3	6	10
1270	25584 Gauthier S, Garcia A, Sano M, Robert P, Senanarong V, et al. Priorities for research consortia on Alzheimer's disease ALZHEIMERS & DEMENTIA. 2010 JUL; 6 (4): 359-362	0	1	2	11
#	Date / Author / Journal	LCS	GCS	LCR	CR
1271	25957 Schneider LS, Kennedy RE, Cutter GR, Alzheimer's Dis Neuroimaging Initi Requiring an amyloid-beta(1-42) biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials ALZHEIMERS & DEMENTIA. 2010 SEP; 6 (5): 367-377	0	1	8	29
1272	25958 Okonkwo OC, Alosco ML, Jerskey BA, Sweet LH, Ott BR, et al. Cerebral atrophy, apolipoprotein E epsilon 4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment ALZHEIMERS & DEMENTIA. 2010 SEP; 6 (5): 404-411	0	0	7	49
1273	26328 Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, et al. Predicting cognitive decline in Alzheimer's disease An integrated analysis ALZHEIMERS & DEMENTIA. 2010 NOV; 6 (6): 431-439	0	0	1	46
1274	26329 Jedrziewski MK, Ewbank DC, Wang HD, Trojanowski JQ Exercise and cognition Results from the National Long Term Care Survey ALZHEIMERS & DEMENTIA. 2010 NOV; 6 (6): 448-455	0	0	1	31
1275	26719 Launer LJ Counting dementia: There is no one "best" way ALZHEIMERS & DEMENTIA. 2011 JAN; 7 (1): 10-14	0	0	3	23
1276	26720 Mayeux R, Reitz C, Brickman AM, Haan MN, Manly JJ, et al. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1 ALZHEIMERS & DEMENTIA. 2011 JAN; 7 (1): 15-34	0	1	7	131
1277	26721 Seshadri S, Beiser A, Au R, Wolf PA, Evans DA, et al. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2 ALZHEIMERS & DEMENTIA. 2011 JAN; 7 (1): 35-52	2	3	17	77
1278	26722 Brookmeyer R, Evans DA, Hebert L, Langa KM, Heeringa SG, et al. National estimates of the prevalence of Alzheimer's disease in the United States ALZHEIMERS & DEMENTIA. 2011 JAN; 7 (1): 61-73	1	1	4	41
1279	26723 Evans DA, Grodstein F, Loewenstein D, Kaye J, Weintraub S Reducing case ascertainment costs in US population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 2 ALZHEIMERS & DEMENTIA. 2011 JAN; 7 (1): 110-123	0	1	9	88
1280	7775 St George-Hyslop PH Genetic factors in the genesis of Alzheimer's disease ALZHEIMERS DISEASE: A COMPENDIUM OF CURRENT THEORIES. 2000; 924: 1-7	10	40	4	34
#	Date / Author / Journal	LCS	GCS	LCR	CR
1281	7776 Lynch C, Mobley W Comprehensive theory of Alzheimer's disease - The effects of cholesterol on membrane receptor trafficking ALZHEIMERS DISEASE: A COMPENDIUM OF CURRENT THEORIES. 2000; 924: 104-111	2	17	1	40
1282	7777 Nixon RA A "protease activation cascade" in the pathogenesis of Alzheimer's disease ALZHEIMERS DISEASE: A COMPENDIUM OF CURRENT THEORIES. 2000; 924: 117-131	15	65	19	117
1283	5636 Fasulo L, Visintin M, Novak M, Cattaneo A Tau truncation in Alzheimer's disease: expression of a fragment encompassing PHF core tau induces apoptosis in COS cells ALZHEIMERS REPORTS. 1998 JAN; 1 (1): 25-31	13	18	12	35
1284	5771 McKeith IG Dementia with Lewy bodies: Clinical and pathological diagnosis ALZHEIMERS REPORTS. 1998 MAR; 1 (2): 83-87	8	22	5	29
1285	5772 Saunders HL, Dickson TC, Vickers JC Immunolocalisation of beta-amyloid precursor protein to plaque- associated synaptic alterations in the early and late stages of Alzheimer's disease ALZHEIMERS REPORTS. 1998 MAR; 1 (2): 111-118	3	5	11	33
1286	5936 Armstrong RA, Cairns NJ, Lantos PL Lewy body and Alzheimer pathology in temporal lobe in dementia with Lewy bodies ALZHEIMERS REPORTS. 1998 MAY; 1 (3): 159-163	2	3	13	27
1287	6736 Fox N Magnetic resonance imaging in Alzheimer's disease: from diagnosis to measuring therapeutic effect ALZHEIMERS REPORTS. 1999 JAN; 2 (1): 5-12	0	6	2	61
1288	6892 Scheper W, Annaert W, Cupers P, Saftig P, De Strooper B Function and dysfunction of the presenilins ALZHEIMERS REPORTS. 1999 MAR; 2 (2): 73-81	4	9	16	81
1289	7058 Pijnenburg YAL, Valk J, Strijers RLM, Jonkman EJ, Scheltens P Dementia in an elderly patient associated with extreme dilatation of the perivascular space ALZHEIMERS REPORTS. 1999 MAY; 2 (3): 137-141	0	0	3	16
1290	7219 Urakami K, Ikeda K, Yamagata K, Ji Y, Wada-Isoe K, et al. Screening for mutations of the tau gene in patients with tauopathy ALZHEIMERS REPORTS. 1999 JUL; 2 (4): 213-215	0	1	4	15
#	Date / Author / Journal	LCS	GCS	LCR	CR
1291	7390 Waddington E, Croft K, Clarnette R, Mori T, Martins R Plasma F-2-isoprostane levels are increased in Alzheimer's disease: evidence of increased oxidative stress in vivo ALZHEIMERS REPORTS. 1999 SEP; 2 (5): 277-282	23	26	2	22
1292	7391 Alafuzoff I, Overmyer M, Helisalmi S, Riekkinen P, Soininen H beta-amyloid load, astroglia and microglia in Alzheimer's disease: association with apoE genotype ALZHEIMERS REPORTS. 1999 SEP; 2 (5): 283-289	0	0	4	28
1293	7561 Rao KSJ, Shanmugavelu P, Shankar SK, Devi RPR, Rao RV, et al. Trace elements in the cerebrospinal fluid in Alzheimer's disease ALZHEIMERS REPORTS. 1999 NOV; 2 (6): 333-338	2	8	8	33
1294	7916 King CE, Dickson TC, Jacobs I, McCormack GH, Riederer BM, et al. Acute CNS axonal injury models a subtype of dystrophic neurite in Alzheimer's disease ALZHEIMERS REPORTS. 2000 JAN-FEB; 3 (1): 31-40	0	6	19	41
1295	8090 Rao KSJ, Anitha S, Latha KS Aluminium-induced neurodegeneration in the hippocampus of aged rabbits mimics Alzheimer's disease ALZHEIMERS REPORTS. 2000 MAR-APR; 3 (2): 83-88	4	9	9	24
1296	8255 Fitzpatrick J, Munzar M, Focht M, Bibiano R, Averback P 7C Gold urinary assay of neural thread protein in Alzheimer's disease ALZHEIMERS REPORTS. 2000 MAY-JUN; 3 (3): 155-159	1	5	7	41
1297	8413 Lee DHS, D'Andrea MR, Plata-Salaman CR, Wang HY Decreased alpha 7 nicotinic acetylcholine receptor protein levels in sporadic Alzheimer's disease hippocampus ALZHEIMERS REPORTS. 2000 JUL-AUG; 3 (4): 217-220	5	18	1	19
1298	8414 Higuchi S, Yoshino A, Matsui T, Matsushita S, Satoh A, et al. A novel PS1 mutation (W165G) in a Japanese family with early-onset Alzheimer's disease ALZHEIMERS REPORTS. 2000 JUL-AUG; 3 (4): 227-231	2	2	1	19
1299	8613 Bennecib M, Gong CX, Wegiel J, Lee MH, Grundke-Iqbal I, et al. Inhibition of protein phosphatases and regulation of tau phosphorylation in rat brain ALZHEIMERS REPORTS. 2000 SEP-DEC; 3 (5-6): 295-304	4	5	33	44
1300	17030 Neef D, Walling AD Dementia with Lewy bodies: An emerging disease AMERICAN FAMILY PHYSICIAN. 2006 APR 1; 73 (7): 1223-1229	4	10	12	33

Date / Author / Journal

LCS

GCS

LCR

1201

6611 Duyckaerts C, Colle MA, Hauw JJ

A sketch of Alzheimer's disease histopathology

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 137-151

113

1202

6612 Tapiola T, Lehtovirta M, Pirttila T, Alafuzoff I, Riekkinen P, et al.

Cerebrospinal fluid aspartate aminotransferase activity is increased in Alzheimer's disease

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 193-197

1203

6613 Grunberg J, Walter J, Haass C

The 18-20 kDa C-terminal fragment of presenilin-1 is the major in vivo substrate for proteases of the caspase family

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 213-220

1204

6614 Goedert M, Crowther RA, Jakes R, Hasegawa M, Smith MJ, et al.

Filamentous tau protein and alpha-synuclein deposits in neurodegenerative diseases

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 245-258

1205

6615 Arawaka S, Sahara N, Lee G, Mori H

Molecular anatomy of tau inclusions with antibodies to specifically recognize tau isoforms

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 259-265

1206

6616 Iqbal K, Alonso AD, Gondal JA, Gong CX, Haque N, et al.

Inhibition of neurofibrillary degeneration: A rational and promising therapeutic target

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 269-280

1207

6617 Novak M, Ugolini G, Fasulo L, Visintin M, Ovecka M, et al.

Truncation of tau and neurodegeneration

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 281-291

1208

6618 Illenberger S, Zheng-Fischhofer Q, Preuss U, Stamer K, Godemann R, et al.

Phosphorylation of tau protein in interphase and mitosis: Influence on microtubules and relationship with PHF-tau in Alzheimer's disease

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 301-310

1209

6619 Wang JZ, Grundke-Iqbal I, Iqbal K

Protein kinase-A and glycogen synthase kinase-3 in combination hyperphosphorylate tau to an Alzheimer's disease-like state

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 311-321

1210

6620 Sisodia SS, Thinakaran G, Borchelt DR, Wong PC, Lee MK, et al.

Function and dysfunction of presenilins in Alzheimer's disease

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 333-346

Date / Author / Journal

LCS

GCS

LCR

1211

6621 Salehi A, Dubelaar EJG, Ishunina TA, Swaab DF

Neuronal activity and genetic background in Alzheimer's disease

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 487-492

1212

6622 Lantos PL

Cracking an enigma: The puzzle of unusual dementias

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 509-522

1213

6623 Schwab C, Steele JC, Schulzer M, McGeer PL

On the possible lifetime of a tangled neuron in the parkinsonism- dementia complex of Guam

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 545-552

1214

6624 Parchi P, Brown P, Capellari S, Gibbs CJ, Gambetti P

Agent strain variation in human prion diseases: Insight from transmission to primates

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 561-567

1215

6625 Genis I, Fisher A, Shohami E, Michaelson DM

Modulation of tau hyperphosphorylation in apoE-deficient mice by muscarinic activation and closed head injury

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 733-740

1216

6626 Tsolaki M, Sakka P, Chatzizisi O, Kyriazis G, Papanastasiou J, et al.

CSF tau protein levels before and after tacrine therapy in patients with dementia of Alzheimer's type

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 741-745

1217

10206 Kakimura J, Kitamura Y, Takata K, Tsuchiya D, Taniguchi T, et al.

Possible involvement of ER chaperone Grp78 on reduced formation of amyloid-beta deposits

ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY. 2002; 977: 327-332

1218

16390 Lee VMY, Trojanowski JQ

Tau focused drug discovery for Alzheimer's disease and related Neuroclegenerative Tauopathies

ALZHEIMER: 100 YEARS AND BEYOND. 2006; : 333-336

1219

18345 Dickey CA, Petrucelli L

Commentary on "Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery." The last stand: The dichotomy of chaperone function in Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2007 JAN; 3 (1): 3-6

1220

18346 Jellinger KA

The enigma of mixed dementia

ALZHEIMERS & DEMENTIA. 2007 JAN; 3 (1): 40-53

162

Date / Author / Journal

LCS

GCS

LCR

1221

18784 Jedrziewski AK, Lee VMY, Trojanowski JQ

Physical activity and cognitive health

ALZHEIMERS & DEMENTIA. 2007 APR; 3 (2): 98-108

1222

19216 Khachaturian ZS

A chapter in the development of Alzheimer's disease research: A case study of public policies on the development and funding of research programs

ALZHEIMERS & DEMENTIA. 2007 JUL; 3 (3): 243-258

1223

19617 Robillard A

Clinical diagnosis of dementia

ALZHEIMERS & DEMENTIA. 2007 OCT; 3 (4): 292-298

1224

19618 Schipper HM

The role of biologic markers in the diagnosis of Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2007 OCT; 3 (4): 325-332

1225

19619 Hogan DB, Bailey P, Carswell A, Clarke B, Cohen C, et al.

Management of mild to moderate Alzheimer's disease and dementia

ALZHEIMERS & DEMENTIA. 2007 OCT; 3 (4): 355-384

298

1226

19620 Hsiung GYR, Sadovnick AD

Genetics and dementia: Risk factors, diagnosis, and management

ALZHEIMERS & DEMENTIA. 2007 OCT; 3 (4): 418-427

1227

19621 Rockwood K, Bouchard RW, Camicioli R, Leger G

Toward a revision of criteria for the dementias

ALZHEIMERS & DEMENTIA. 2007 OCT; 3 (4): 428-440

133

1228

20279 Trojanowski JQ, Hendricks JC, Jedrziewski K, Johnson FB, Michel KE, et al.

Exploring human/animal intersections: Converging lines of evidence in comparative models of aging

ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): 1-5

1229

20280 Foster NL, Wanga AY, Tasdizen T, Fletcher PT, Hoffman JM, et al.

Realizing the potential of positron emission tomography with F-18- fluorodeoxyglucose to improve the treatment of Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S29-S36

1230

20281 Hodes RJ, Buckholtz N, Cahan V, Morrison-Bogorad M

Eyes on the prize: Federal Alzheimer's research effort aims to facilitate interventions

ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S37-S47

Date / Author / Journal

LCS

GCS

LCR

1231

20282 Hampel H, Buerger K, Teipel SJ, Bokde ALW, Zetterberg H, et al.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): 38-48

1232

20283 Koeppe RA, Gilman S, Junck L, Wernette K, Frey KA

Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[C-11]dihydrotetrabenazine positron emission tomography

ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S67-S76

1233

20284 Kuller LH, Lopez OL

Dementia: Is it time for a change in focus?

ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S77-S84

1234

20285 Sabbagh MN, Richardson S, Relkinc N

Disease-modifying approaches to Alzheimer's disease: Challenges and opportunities - Lessons from donepezil therapy

ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S109-S118

1235

20286 Jackson CE, Snyder PJ

Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S137-S143

1236

20590 Salloway S, Mintzer J, Weiner MF, Cummings JL

Disease-modifying therapies in Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2008 MAR; 4 (2): 65-79

172

1237

20591 Ivinson AJ, Lane R, May PC, Hosford DA, Carrillo MC, et al.

Partnership between academia and industry for drug discovery in Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2008 MAR; 4 (2): 80-88

1238

20592 Trojanowski JQ, Duff K, Fillit H, Koroshetz W, Kuret J, et al.

New directions for frontotemporal dementia drug discovery

ALZHEIMERS & DEMENTIA. 2008 MAR; 4 (2): 89-93

1239

20593 Schenk D

Commentary on "New directions for frontotemporal dementia drug discovery." Do we know enough to develop meaningful treatments for frontotemporal dementia?

ALZHEIMERS & DEMENTIA. 2008 MAR; 4 (2): 94-95

1240

20911 Siemers ER, Paul SM

Commentary on "A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium"

ALZHEIMERS & DEMENTIA. 2008 MAY; 4 (3): 171-173

Date / Author / Journal

LCS

GCS

LCR

1241

21814 Chiang HH, Rosvall L, Brohede J, Axelman K, Bjork BF, et al.

Progranulin mutation causes frontotemporal dementia in the Swedish Karolinska family

ALZHEIMERS & DEMENTIA. 2008 NOV; 4 (6): 414-420

1242

21815 Griffith HR, den Hollander JA, Okonkwo OC, O'Brien T, Watts RL, et al.

Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia

ALZHEIMERS & DEMENTIA. 2008 NOV; 4 (6): 421-427

1243

21816 Bain LJ, Jedrziewski K, Morrison-Bogorad M, Albert M, Cotman C, et al.

Healthy brain aging: A meeting report from the Sylvan M. Cohen Annual Retreat of the University of Pennsylvania Institute on Aging

ALZHEIMERS & DEMENTIA. 2008 NOV; 4 (6): 443-446

1244

22630 Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, et al.

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008

ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 85-92

1245

22631 Petersen RC

Commentary on "A roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A national registry on aging

ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 105-107

1246

22632 Simpkins JW, Gatson JW, Wigginton JG

Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients

ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 143-146

1247

22633 Carrillo MC, Blackwell A, Hampel H, Lindborg J, Sperling R, et al.

Early risk assessment for Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 182-196

124

1248

22958 Mebane-Sims I, Alzheimer's Association

2009 Alzheimer's disease facts and figures

ALZHEIMERS & DEMENTIA. 2009 MAY; 5 (3): 234-270

126

1249

23258 Frisoni GB, Prestia A, Zanetti O, Galluzzi S, Romano M, et al.

Markers of Alzheimer's disease in a population attending a memory clinic

ALZHEIMERS & DEMENTIA. 2009 JUL; 5 (4): 307-317

1250

23259 Black R, Greenberg B, Ryan JM, Posner H, Seeburger J, et al.

Scales as outcome measures for Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2009 JUL; 5 (4): 324-339

115

Date / Author / Journal

1251

Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier"

ALZHEIMERS & DEMENTIA. 2009 SEP; 5 (5): 433-434

1252

23945 Lukens JN, Van Deerlin V, Clark CM, Xie SX, Johnson FB

Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2009 NOV; 5 (6): 463-469

1253

24542 Itzhaki RF, Wozniak MA

Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?

ALZHEIMERS & DEMENTIA. 2010 JAN; 6 (1): 83-84

1254

24889 Khachaturian ZS, Barnes D, Einstein R, Johnson S, Lee VMY, et al.

Developing a national strategy to prevent dementia: Leon Thal Symposium 2009

ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 89-97

1255

24890 Brunnstrom H, Rawshani N, Zetterberg H, Blennow K, Minthon L, et al.

Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses

ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 104-109

1256

24891 Xu SH, Brunden KR, Trojanowski JQ, Lee VMY

Characterization of tau fibrillization in vitro

ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 110-117

1257

24892 Snyder PJ

Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." The rationale for a National Institutional Review Board for neurodegenerative diseases

ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 135-137

1258

24893 Einstein R

Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Developing a blood test for Alzheimer's disease using advanced genomic expression technology

ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 147-149

1259

24894 Trojanowski JQ, Arnold SE, Karlawish JH, Brunden K, Cary M, et al.

Design of comprehensive Alzheimer's disease centers to address unmet national needs

ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 150-155

1260

24895 Sabbagh MN

Commentary on "Design of comprehensive Alzheimer's disease centers to address unmet national needs"

ALZHEIMERS & DEMENTIA. 2010 MAR; 6 (2): 156-157

Date / Author / Journal

LCS

GCS

LCR

1261

25250 Weiner MW, Aisen PS, Jack CR, Jagust WJ, Trojanowski JQ, et al.

The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans

ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 202-211

1262

25251 Jack CR, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, et al.

Update on the Magnetic Resonance Imaging core of the Alzheimer's Disease Neuroimaging Initiative

ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 212-220

1263

25252 Jagust WJ, Bandy D, Chen KW, Foster NL, Landau SM, et al.

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core

ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 221-229

1264

25253 Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, et al.

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects

ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 230-238

1265

25254 Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, et al.

Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans

ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 239-246

1266

25255 Beckett LA, Harvey DJ, Gamst A, Donohue M, Kornak J, et al.

The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes

ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 257-264

1267

25256 Saykin AJ, Shen L, Foroud TM, Potkin SG, Swaminathan S, et al.

Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans

ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 265-273

1268

25257 Cairns NJ, Taylor-Reinwald L, Morris JC, Alzheimer's Dis Neuroimaging Initi

Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: The essential role of the Neuropathology Core

ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 274-279

1269

25258 Frisoni GB

Alzheimer's Disease Neuroimaging Initiative in Europe

ALZHEIMERS & DEMENTIA. 2010 MAY; 6 (3): 280-285

1270

25584 Gauthier S, Garcia A, Sano M, Robert P, Senanarong V, et al.

Priorities for research consortia on Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2010 JUL; 6 (4): 359-362

Date / Author / Journal

LCS

GCS

LCR

1271

25957 Schneider LS, Kennedy RE, Cutter GR, Alzheimer's Dis Neuroimaging Initi

Requiring an amyloid-beta(1-42) biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials

ALZHEIMERS & DEMENTIA. 2010 SEP; 6 (5): 367-377

1272

25958 Okonkwo OC, Alosco ML, Jerskey BA, Sweet LH, Ott BR, et al.

Cerebral atrophy, apolipoprotein E epsilon 4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment

ALZHEIMERS & DEMENTIA. 2010 SEP; 6 (5): 404-411

1273

26328 Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, et al.

Predicting cognitive decline in Alzheimer's disease An integrated analysis

ALZHEIMERS & DEMENTIA. 2010 NOV; 6 (6): 431-439

1274

26329 Jedrziewski MK, Ewbank DC, Wang HD, Trojanowski JQ

Exercise and cognition Results from the National Long Term Care Survey

ALZHEIMERS & DEMENTIA. 2010 NOV; 6 (6): 448-455

1275

26719 Launer LJ

Counting dementia: There is no one "best" way

ALZHEIMERS & DEMENTIA. 2011 JAN; 7 (1): 10-14

1276

26720 Mayeux R, Reitz C, Brickman AM, Haan MN, Manly JJ, et al.

Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1

ALZHEIMERS & DEMENTIA. 2011 JAN; 7 (1): 15-34

131

1277

26721 Seshadri S, Beiser A, Au R, Wolf PA, Evans DA, et al.

Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2

ALZHEIMERS & DEMENTIA. 2011 JAN; 7 (1): 35-52

1278

26722 Brookmeyer R, Evans DA, Hebert L, Langa KM, Heeringa SG, et al.

National estimates of the prevalence of Alzheimer's disease in the United States

ALZHEIMERS & DEMENTIA. 2011 JAN; 7 (1): 61-73

1279

26723 Evans DA, Grodstein F, Loewenstein D, Kaye J, Weintraub S

Reducing case ascertainment costs in US population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 2

ALZHEIMERS & DEMENTIA. 2011 JAN; 7 (1): 110-123

1280

7775 St George-Hyslop PH

Genetic factors in the genesis of Alzheimer's disease

ALZHEIMERS DISEASE: A COMPENDIUM OF CURRENT THEORIES. 2000; 924: 1-7

Date / Author / Journal

LCS

GCS

LCR

1281

7776 Lynch C, Mobley W

Comprehensive theory of Alzheimer's disease - The effects of cholesterol on membrane receptor trafficking

ALZHEIMERS DISEASE: A COMPENDIUM OF CURRENT THEORIES. 2000; 924: 104-111

1282

7777 Nixon RA

A "protease activation cascade" in the pathogenesis of Alzheimer's disease

ALZHEIMERS DISEASE: A COMPENDIUM OF CURRENT THEORIES. 2000; 924: 117-131

117

1283

5636 Fasulo L, Visintin M, Novak M, Cattaneo A

Tau truncation in Alzheimer's disease: expression of a fragment encompassing PHF core tau induces apoptosis in COS cells

ALZHEIMERS REPORTS. 1998 JAN; 1 (1): 25-31

1284

5771 McKeith IG

Dementia with Lewy bodies: Clinical and pathological diagnosis

ALZHEIMERS REPORTS. 1998 MAR; 1 (2): 83-87

1285

5772 Saunders HL, Dickson TC, Vickers JC

Immunolocalisation of beta-amyloid precursor protein to plaque- associated synaptic alterations in the early and late stages of Alzheimer's disease

ALZHEIMERS REPORTS. 1998 MAR; 1 (2): 111-118

1286

5936 Armstrong RA, Cairns NJ, Lantos PL

Lewy body and Alzheimer pathology in temporal lobe in dementia with Lewy bodies

ALZHEIMERS REPORTS. 1998 MAY; 1 (3): 159-163

1287

6736 Fox N

Magnetic resonance imaging in Alzheimer's disease: from diagnosis to measuring therapeutic effect

ALZHEIMERS REPORTS. 1999 JAN; 2 (1): 5-12

1288

6892 Scheper W, Annaert W, Cupers P, Saftig P, De Strooper B

Function and dysfunction of the presenilins

ALZHEIMERS REPORTS. 1999 MAR; 2 (2): 73-81

1289

7058 Pijnenburg YAL, Valk J, Strijers RLM, Jonkman EJ, Scheltens P

Dementia in an elderly patient associated with extreme dilatation of the perivascular space

ALZHEIMERS REPORTS. 1999 MAY; 2 (3): 137-141

1290

7219 Urakami K, Ikeda K, Yamagata K, Ji Y, Wada-Isoe K, et al.

Screening for mutations of the tau gene in patients with tauopathy

ALZHEIMERS REPORTS. 1999 JUL; 2 (4): 213-215

Date / Author / Journal

LCS

GCS

LCR

1291

7390 Waddington E, Croft K, Clarnette R, Mori T, Martins R

Plasma F-2-isoprostane levels are increased in Alzheimer's disease: evidence of increased oxidative stress in vivo

ALZHEIMERS REPORTS. 1999 SEP; 2 (5): 277-282

1292

7391 Alafuzoff I, Overmyer M, Helisalmi S, Riekkinen P, Soininen H

beta-amyloid load, astroglia and microglia in Alzheimer's disease: association with apoE genotype

ALZHEIMERS REPORTS. 1999 SEP; 2 (5): 283-289

1293

7561 Rao KSJ, Shanmugavelu P, Shankar SK, Devi RPR, Rao RV, et al.

Trace elements in the cerebrospinal fluid in Alzheimer's disease

ALZHEIMERS REPORTS. 1999 NOV; 2 (6): 333-338

1294

7916 King CE, Dickson TC, Jacobs I, McCormack GH, Riederer BM, et al.

Acute CNS axonal injury models a subtype of dystrophic neurite in Alzheimer's disease

ALZHEIMERS REPORTS. 2000 JAN-FEB; 3 (1): 31-40

1295

8090 Rao KSJ, Anitha S, Latha KS

Aluminium-induced neurodegeneration in the hippocampus of aged rabbits mimics Alzheimer's disease

ALZHEIMERS REPORTS. 2000 MAR-APR; 3 (2): 83-88

1296

8255 Fitzpatrick J, Munzar M, Focht M, Bibiano R, Averback P

7C Gold urinary assay of neural thread protein in Alzheimer's disease

ALZHEIMERS REPORTS. 2000 MAY-JUN; 3 (3): 155-159

1297

8413 Lee DHS, D'Andrea MR, Plata-Salaman CR, Wang HY

Decreased alpha 7 nicotinic acetylcholine receptor protein levels in sporadic Alzheimer's disease hippocampus

ALZHEIMERS REPORTS. 2000 JUL-AUG; 3 (4): 217-220

1298

8414 Higuchi S, Yoshino A, Matsui T, Matsushita S, Satoh A, et al.

A novel PS1 mutation (W165G) in a Japanese family with early-onset Alzheimer's disease

ALZHEIMERS REPORTS. 2000 JUL-AUG; 3 (4): 227-231

1299

8613 Bennecib M, Gong CX, Wegiel J, Lee MH, Grundke-Iqbal I, et al.

Inhibition of protein phosphatases and regulation of tau phosphorylation in rat brain

ALZHEIMERS REPORTS. 2000 SEP-DEC; 3 (5-6): 295-304

1300

17030 Neef D, Walling AD

Dementia with Lewy bodies: An emerging disease

AMERICAN FAMILY PHYSICIAN. 2006 APR 1; 73 (7): 1223-1229

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records